ARCHIVES

Research teams link response to Iressa to mutations in EGF receptor.

This article is from The Cancer Letter archive.

Vol. 30 No. 18 | April 30, 2004

Download PDF Visit The Full Archive

Related Articles

Greenberg: More Work Needs to be Done

November 7, 2014

Biomarker Test Outperforms PSA and Gleason Score in Study

July 26, 2013

Perjeta, Herceptin & Docetaxel Combination Extended Survival in HER2-Positive Disease

December 28, 2012

Adjuvant BC Therapy Is Topic Of NIH Consensus Conference.

January 28, 2000

Surprise Finding On HRT Stops Large Trial, Women Advised To Reconsider Long-Term Use Due to Increased Breast Cancer Risk

July 12, 2002

If You Were On ODAC: Experts Suggest Questions For May 10 Advisory Meeting.

March 16, 2007